Reviewing IceCure Medical (NASDAQ:ICCM) and First Choice Healthcare Solutions (OTCMKTS:FCHS)

IceCure Medical (NASDAQ:ICCM) and First Choice Healthcare Solutions (OTCMKTS:FCHS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Valuation and Earnings

This table compares IceCure Medical and First Choice Healthcare Solutions”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.29 million	16.03	-$15.32 million	($0.16)	-5.61
First Choice Healthcare Solutions	$30,000.00	12.20	-$3.85 million	($0.09)	-0.12

First Choice Healthcare Solutions has lower revenue, but higher earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than First Choice Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

IceCure Medical has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500. Comparatively, First Choice Healthcare Solutions has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Profitability

This table compares IceCure Medical and First Choice Healthcare Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-317.62%	-136.96%	-71.46%
First Choice Healthcare Solutions	N/A	N/A	-63.12%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for IceCure Medical and First Choice Healthcare Solutions, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	0	0	2	1	3.33
First Choice Healthcare Solutions	0	0	0	0	0.00

IceCure Medical presently has a consensus target price of $2.3850, indicating a potential upside of 165.50%. Given IceCure Medical’s stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than First Choice Healthcare Solutions.

Insider and Institutional Ownership

0.6% of IceCure Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 30.8% of First Choice Healthcare Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

First Choice Healthcare Solutions beats IceCure Medical on 8 of the 15 factors compared between the two stocks.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

About First Choice Healthcare Solutions

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.